What is lipodystrophy and why is it so rare? Lipodystrophy is a condition that impacts a person’s ability to produce and store fat. It can be categorised into different forms, including acquired and ...

Lipodystrophy is a term used to describe a group of varying disorders which are characterized by abnormal loss of body fat over some or all body areas, with a strong tendency to develop insulin ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. I saw three patients recently. One was an established ...

Lipodystrophy is a medical condition characterized by complete or partial loss of adipose tissue. Not infrequently, lipodystrophy occurs in combination with pathological accumulation of adipose tissue ...

The US Food and Drug Administration (FDA) has approved Amylin Pharmaceuticals' Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency, in addition ...

A Food and Drug Administration (FDA) advisory panel has voted 11 to 1 in favor of the use of metreleptin (Myalept, Bristol-Myers Squibb/AstraZeneca) for the treatment of pediatric and adult patients ...

Please provide your email address to receive an email when new articles are posted on . Evidence remains limited regarding diagnostic criteria and recommendations for the treatment of lipodystrophy in ...

This page lists all known medications that could potentially lead to 'Acquired Lipodystrophy' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest analysis report on drug pipeline for lipodystrophy syndrome. The report includes a detailed analysis of the pipeline molecules under ...

The introduction of highly active anti-retroviral treatment (HAART), based on the administration of a combination of anti-retroviral drugs from different families, has had considerable success in ...